ProCE Banner Activity

Contemporary Care of Patients With Advanced Ovarian Cancer: Expert Answers to FAQ

Clinical Thought

Expert faculty answer questions about patient education and communication about PARP inhibitors and how they are addressing platinum drug shortages in the care of their patients with advanced ovarian cancer.

Released: June 23, 2023

Share

Faculty

Sarah Hayward

Sarah Hayward, PharmD, BCOP

Clinical Pharmacy Specialist, Gynecologic OncologyStephenson Cancer Center at OU HealthOklahoma City, Oklahoma

Amy Indorf

Amy Indorf, PharmD, BCOP

Clinical Assistant Professor
University of Washington
School of Pharmacy
Clinical Oncology Pharmacist
UW Medicine
Fred Hutchinson Cancer Center
Seattle, Washington

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

Supporters

Supported by educational grants from GSK and Novocure, Inc.

GSK

Novocure, Inc

Partners

Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner